Effects of slow-release octreotide on urinary metanephrine excretion and plasma chromogranin A and catecholamine levels in patients with malignant or recurrent phaeochromocytoma.

Source:http://linkedlifedata.com/resource/pubmed/id/12390337

Download in:

View as

General Info

PMID
12390337